Biological depth
Experience across strain selection, microbial physiology and production-system development.
BACTERIA · YEAST · FUNGI
We develop and scale microbial processes that turn renewable carbon into PHB — a biobased, biodegradable polymer for a circular material future.
Founded in 2020 in Eskisehir, Innovaplast brings multidisciplinary biotechnology expertise together with more than 15 years of microbial PHA know-how. We connect scientific discovery, bioprocess engineering and practical production experience to develop reliable, scalable and sustainable biological solutions.
Our role is not limited to proving that a microorganism can make a molecule. We define how that biology can become a repeatable manufacturing process.
ESKISEHIR · TURKIYE / EST. 2020Experience across strain selection, microbial physiology and production-system development.
BACTERIA · YEAST · FUNGIUpstream, scale-up, downstream and analytical validation are designed as one connected workflow.
ONE DEVELOPMENT PLATFORMDecisions are driven by reproducibility, process evidence and application-relevant performance.
DATA BEFORE CLAIMSWe develop biological processes with scale, resource efficiency and real manufacturing constraints in view.
LAB → PILOT → INDUSTRYTo translate biotechnology into manufacturing systems that reduce dependence on fossil resources and create measurable value for sustainable industries.
Innovaplast is an industrial biotechnology platform—not only a fermentation operation. We combine biological diversity, sustainable feedstocks, process development, scale-up and responsible downstream technologies to turn microorganisms into manufacturing systems.
Screen, select and characterize bacteria, yeasts and filamentous fungi for the target molecule and feedstock.
BACTERIA · YEAST · FUNGIDevelop media and operating strategy in laboratory studies, then optimize under controlled conditions in 1–6 L benchtop bioreactors.
LAB → 1–6 LTranslate biological performance into an integrated pilot and industrial process, connecting robust upstream operation with scalable downstream recovery.
PILOT → INDUSTRIAL SCALEApply product-specific separation, purification and finishing routes with resource efficiency and environmental impact in mind.
GREEN DOWNSTREAMWe engineer sustainability into the process from the first feedstock decision to final product recovery—connecting renewable resources, biological conversion and responsible downstream technologies.
Production energy supplied from on-site solar panels.
RENEWABLE POWERAgricultural residues and renewable carbon and nitrogen sources replace conventional inputs where technically suitable.
SUSTAINABLE C + NBacteria, yeasts and fungi convert selected resources into high-value biological products.
MICROBIAL MANUFACTURINGProduct-specific separation and purification routes are designed around resource and environmental performance.
RESPONSIBLE DOWNSTREAMPHA is not a single polymer. By controlling biology, carbon source and process conditions, its monomer composition can be directed toward different balances of stiffness, flexibility and processing behaviour.
Poly[(R)-3-hydroxybutyrate]
A highly crystalline, biobased thermoplastic produced and stored intracellularly by microorganisms. Our core material platform for application development and high-purity biomaterial research.
Composition-led R&D pathways
PHBHV grades with different 3-hydroxyvalerate ratios are being developed to tune crystallinity, flexibility and processing behaviour.
IN DEVELOPMENTMultiple HV ratios will support application-specific material profiles rather than a single fixed copolymer composition.
DEVELOPMENT PROGRAMMEWe develop PHB from the market requirement backwards—matching grade, purity, processing route and validation scope to the needs of each sector. Our focus is deliberately selective: applications where biological origin, biodegradability or high purity can create a defensible material advantage.
PHB as a biobased polymer input for rigid products, selected packaging structures, blends and compounds developed around defined processing and end-of-life requirements.
PHB-based concepts for selected cosmetic and personal-care formats where particle properties, biological origin and formulation compatibility can provide differentiated value.
PHBMED for pre-commercial biomaterial studies, research prototypes and application-specific evaluation where purity and material traceability are critical starting parameters.
Material selection → processing assessment → prototype → application-specific validation
NO UNIVERSAL-FIT CLAIMSInnovaplast participates in collaborative R&D programmes that connect circular feedstocks, microbial process development and pilot-scale validation—translating consortium knowledge into industrially credible biomanufacturing pathways.

Developing integrated chemical and biological pathways that transform PE waste into value-added chemicals and new biodegradable, fully recyclable polyesters.
Developing routes from residue-derived feedstocks to PHB and other high-value biobased products.
Using process insight to improve resource efficiency, production consistency and scale-aware decisions.
Research · industry · technology
















































































Selected institutions within Innovaplast's collaboration ecosystem.
BUILD WITH US ↗Engage Innovaplast at the stage that matches your objective. We can support a focused material assessment, co-develop a biological production process or contribute industrial biotechnology capability to a larger R&D programme.
Define the appropriate grade, technical requirements and evidence pathway for a focused application assessment.
Connect strain, feedstock and operating strategy to a controlled, repeatable process with scale-up in view from the beginning.
Translate consortium research into pilot-scale evidence, application-relevant data and a realistic route toward industrial implementation.
We make key governance policies and current certification records accessible to partners, funders and stakeholders. Documents are provided with clear scope and revision information to support transparent evaluation.
Our institutional framework for gender equality, inclusive participation, monitoring and accountable implementation. Published for the 2023–2027 period.
VIEW DOCUMENT · PDF↗Current management-system certificates are available with their certified scope, issuing body and validity period.
Scope · issuing authority · revision · validity
VERIFIABLE BY DESIGNConnect with us for PHB materials, scalable bioprocess development, pilot-scale validation or industrial R&D collaboration.
Materials · Process development · Collaborative R&D